Advanced (Metastatic) Breast Cancer

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Support Groups calendar

Published July 9, 2009, 12:41 pm, Concord Transcript

Support group listings are compiled from information provided by area representatives of each group. Listings run on a space-available basis. To have a support group considered, submit complete information to Kathy Bennett, Contra Costa Times, P.O. Box 8099, Walnut Creek, CA 94596; e-mail kbennett@bayareanewsgroup ; or fax 925-943-8362.

Discover News | Full Story


Denosumab Demonstrates Superiority Over Zometa(R) In Pivotal Phase 3 Head-to-Head Trial In Breast Cancer Patients With ...

Published July 8, 2009, 4:17 am, Medical News Today

Amgen (Nasdaq: AMGN) announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,049 patients with advanced breast cancer met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.

Discover News | Full Story


Amgen shares climb 15% on bone-drug trial

Published July 8, 2009, 3:42 am, Market Watch

Shares of Amgen surge after the biotech company says a late-stage trial of a bone drug works better than one from Novartis.

Discover News | Full Story


A Big Win For Amgen

Published July 7, 2009, 9:49 pm, Forbes

A closely watched study shows the company's most important pipeline drug is more effective than Wall Street expected.

Discover News | Full Story


Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial in Breast Cancer Patients With ...

Published July 7, 2009, 6:57 pm, redOrbit

THOUSAND OAKS, Calif., July 7 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced that a pivotal, Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,049 patients with advanced breast cancer met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.

Discover News | Full Story


(AFX UK Focus) 2009-07-07 22:08 U.S. FDA advisory meetings through Aug 13

Published July 7, 2009, 2:39 pm, Interactive Investor

THIS DIARY IS FILED AS THE FOOD AND DRUG ADMINISTRATION UPDATES ITS SCHEDULE. ALL TIMES EDT/GMT. For more information on the FDA's Advisory Committee meetings, see: http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm

Discover News | Full Story


(AFX UK Focus) 2009-07-06 15:03 STOCKS NEWS UK-Oxford Bio rises on TroVax FDA boost

Published July 6, 2009, 7:23 am, Interactive Investor

STOCKS NEWS Reuters Results diary Europe Real-time Equity News UK Stocks on the move UK smallcaps UK smallcaps news

Discover News | Full Story


Why so late?

Published July 4, 2009, 4:52 pm, The Star

Despite efforts to educate women about early detection of breast cancer, many approach doctors in the late stages of the disease. What’s the problem?

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a